pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4697 |
Genomic Coordinates | chr11: 133898504 - 133898581 |
Description | Homo sapiens miR-4697 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4697-5p | |||||||||||||||||||||
Sequence | 10| AGGGGGCGCAGUCACUGACGUG |31 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MEN1 | ||||||||||||||||||||
Synonyms | MEAI, SCG2 | ||||||||||||||||||||
Description | menin 1 | ||||||||||||||||||||
Transcript | NM_000244 | ||||||||||||||||||||
Other Transcripts | NM_130799 , NM_130800 , NM_130801 , NM_130802 , NM_130803 , NM_130804 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MEN1 | |||||||||||||||||||||
3'UTR of MEN1 (miRNA target sites are highlighted) |
>MEN1|NM_000244|3'UTR 1 ACTACTGGGGACTTCGGACCGCTTGTGGGGACCCAGGCTCCGCCCTTAGTCCCCCAACTCTGAGCCCATGTTCTGCCCCC 81 AGCCCAAAGGGGACAGGCCTCACCTCTACCCAAACCCTAGGTTCCCGGTCCCGAGTACAGTCTGTATCAAACCCACGATT 161 TTCTCCAGCTCAGAACCCAGGGCTCTGCCCCAGTCGTTAGAATATAGGTCTCTTCTCCCAGAATCCCAGCCGGCCAATGG 241 AAACCTCACGCTGGGTCCTAATTACCAGTCTTTAAAGGCCCAGCCCCTAGAAACCCAAGCTCCTCCTCGGAACCGCTCAC 321 CTAGAGCCAGACCAACGTTACTCAGGGCTCCTCCCAGCTTGTAGGAGCTGAGGTTTCACCCTTAACCCAAGGAGCACAGG 401 TCCCACCTCCAGCCCGGGAGCCTAGGACCACTCAGCCCCTAGGAGTATATTTCCGCACTTCAGAATTCCATATCTTGCGA 481 ATCCAAGCTCCCTGCCCCAAATAACTTCAGTCCTGCTCCAGAATTTGGAAATCCTAGTTTCCTCTCCTTCGTATCCCGAG 561 TCTGGGACACAAAACTCCGCCCCCAGCCTATGAGCATCCTGAGCCCCGCCCTCTTCCTGACGAAACTGGCCCCGGATCAG 641 AGCAGGACCTCCCTTCCGACCCTCTGGGAACCTCCCAGAGGTCCAGCCCATCTCGGAGCATCCCGGAGGAAATCTGCAGA 721 GGGTTAGGAGTGGGTGACAAGAGCCTGATCTCTTCCTGTTTTGTACATAGATTTATTTTTCAGTTCCAAGAAAGATGAAT 801 ACATTTTGTTAAAAAAAATAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177600. RNA binding protein: AGO2. Condition:p53_V_Ago_CLIP_2_2
PAR-CLIP data was present in ERX177612. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_2
PAR-CLIP data was present in ERX177624. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_2
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_000244 | 3UTR | GUUCUGCCCCCAGCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_000244 | 3UTR | GUUCUGCCCCCAGCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000377316.2 | 3UTR | CCCUUAGUCCCCCAACUCUGAGCCCAUGUUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
67 hsa-miR-4697-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT441332 | C19orf26 | CACN beta subunit associated regulatory protein | 2 | 4 | ||||||||
MIRT451390 | FARSA | phenylalanyl-tRNA synthetase alpha subunit | 2 | 2 | ||||||||
MIRT452310 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT455043 | MEN1 | menin 1 | 2 | 2 | ||||||||
MIRT455256 | DDX39B | DExD-box helicase 39B | 2 | 10 | ||||||||
MIRT461279 | COX10 | COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor | 2 | 2 | ||||||||
MIRT464945 | TXLNA | taxilin alpha | 2 | 4 | ||||||||
MIRT468043 | SIK1 | salt inducible kinase 1 | 2 | 2 | ||||||||
MIRT472523 | NACC1 | nucleus accumbens associated 1 | 2 | 2 | ||||||||
MIRT472929 | MSN | moesin | 2 | 2 | ||||||||
MIRT473247 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT475828 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT478744 | CS | citrate synthase | 2 | 2 | ||||||||
MIRT480081 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT483482 | STMN3 | stathmin 3 | 2 | 4 | ||||||||
MIRT483643 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 4 | ||||||||
MIRT483721 | THSD4 | thrombospondin type 1 domain containing 4 | 2 | 2 | ||||||||
MIRT484539 | BARHL1 | BarH like homeobox 1 | 2 | 6 | ||||||||
MIRT486041 | WSCD1 | WSC domain containing 1 | 2 | 4 | ||||||||
MIRT486142 | SIX5 | SIX homeobox 5 | 2 | 6 | ||||||||
MIRT486498 | MYH11 | myosin heavy chain 11 | 2 | 2 | ||||||||
MIRT486977 | STEAP3 | STEAP3 metalloreductase | 2 | 4 | ||||||||
MIRT487279 | AGPAT6 | glycerol-3-phosphate acyltransferase 4 | 2 | 4 | ||||||||
MIRT487742 | MIB2 | mindbomb E3 ubiquitin protein ligase 2 | 2 | 2 | ||||||||
MIRT487987 | RXRB | retinoid X receptor beta | 2 | 2 | ||||||||
MIRT488338 | PAX2 | paired box 2 | 2 | 2 | ||||||||
MIRT488668 | WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 2 | 4 | ||||||||
MIRT488752 | FXYD1 | FXYD domain containing ion transport regulator 1 | 2 | 2 | ||||||||
MIRT488812 | TBC1D28 | TBC1 domain family member 28 | 2 | 2 | ||||||||
MIRT489380 | RAB11B | RAB11B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT489744 | TACC3 | transforming acidic coiled-coil containing protein 3 | 2 | 2 | ||||||||
MIRT489960 | GNB2 | G protein subunit beta 2 | 2 | 2 | ||||||||
MIRT490418 | VPS51 | VPS51, GARP complex subunit | 2 | 4 | ||||||||
MIRT490639 | FEM1A | fem-1 homolog A | 2 | 2 | ||||||||
MIRT491086 | MSI1 | musashi RNA binding protein 1 | 2 | 4 | ||||||||
MIRT491298 | VGF | VGF nerve growth factor inducible | 2 | 4 | ||||||||
MIRT491366 | SLC12A5 | solute carrier family 12 member 5 | 2 | 2 | ||||||||
MIRT492464 | RASD1 | ras related dexamethasone induced 1 | 2 | 4 | ||||||||
MIRT492872 | NFIX | nuclear factor I X | 2 | 2 | ||||||||
MIRT492951 | NEUROD2 | neuronal differentiation 2 | 2 | 2 | ||||||||
MIRT493704 | H2AFX | H2A histone family member X | 2 | 2 | ||||||||
MIRT493977 | EIF1 | eukaryotic translation initiation factor 1 | 2 | 4 | ||||||||
MIRT500360 | ZNF385A | zinc finger protein 385A | 2 | 2 | ||||||||
MIRT501154 | SLC10A7 | solute carrier family 10 member 7 | 2 | 6 | ||||||||
MIRT509625 | RRP7A | ribosomal RNA processing 7 homolog A | 2 | 4 | ||||||||
MIRT512232 | ATG2A | autophagy related 2A | 2 | 8 | ||||||||
MIRT529822 | ARGFX | arginine-fifty homeobox | 2 | 4 | ||||||||
MIRT531179 | SIGLEC12 | sialic acid binding Ig like lectin 12 (gene/pseudogene) | 2 | 2 | ||||||||
MIRT538971 | BCL7A | BCL tumor suppressor 7A | 2 | 2 | ||||||||
MIRT548357 | ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 | 2 | 4 | ||||||||
MIRT553634 | TJAP1 | tight junction associated protein 1 | 2 | 2 | ||||||||
MIRT558050 | EVI5L | ecotropic viral integration site 5 like | 2 | 2 | ||||||||
MIRT562548 | CCDC71L | coiled-coil domain containing 71 like | 2 | 4 | ||||||||
MIRT568941 | RUNX3 | runt related transcription factor 3 | 2 | 2 | ||||||||
MIRT569114 | ONECUT3 | one cut homeobox 3 | 2 | 2 | ||||||||
MIRT573591 | CERS1 | ceramide synthase 1 | 2 | 2 | ||||||||
MIRT619317 | ARHGAP18 | Rho GTPase activating protein 18 | 2 | 2 | ||||||||
MIRT621202 | ARPC1B | actin related protein 2/3 complex subunit 1B | 2 | 2 | ||||||||
MIRT628844 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT670497 | LYRM4 | LYR motif containing 4 | 2 | 2 | ||||||||
MIRT670545 | SHISA2 | shisa family member 2 | 2 | 2 | ||||||||
MIRT671026 | PCDHB2 | protocadherin beta 2 | 2 | 2 | ||||||||
MIRT688989 | ATP6AP1 | ATPase H+ transporting accessory protein 1 | 2 | 2 | ||||||||
MIRT709275 | MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 2 | 2 | ||||||||
MIRT715084 | ELOF1 | elongation factor 1 homolog | 2 | 2 | ||||||||
MIRT718348 | NPBWR1 | neuropeptides B and W receptor 1 | 2 | 2 | ||||||||
MIRT737406 | MMP7 | matrix metallopeptidase 7 | 2 | 0 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|